Prothena Corporation PLC/ IE00B91XRN20 /
8/30/2024 10:00:00 PM | Chg. +0.7100 | Volume | Bid12:55:48 AM | Ask12:55:48 AM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
22.2700USD | +3.29% | 300,305 Turnover: 4.66 mill. |
21.5000Bid Size: 100 | 23.8800Ask Size: 100 | 888.91 mill.USD | 0.00% | - |
GlobeNewswire
8/5
ORIC Pharmaceuticals Expands Leadership Team with the Appointment of Keith Lui as Senior Vice Presid...
GlobeNewswire
3/28/2022
Prothena Announces FDA Clearance of IND for PRX012, a Subcutaneous Anti-Amyloid Beta Antibody Under ...
GlobeNewswire
3/16/2022
Prothena Presents New Data for Alzheimer’s and Parkinson’s Disease Programs at AD/PD 2022
GlobeNewswire
2/17/2022
Prothena Reports Fourth Quarter and Full Year 2021 Financial Results, and Provides Financial Guidanc...
GlobeNewswire
2/10/2022
Prothena to Report Fourth Quarter and Full Year 2021 Financial Results and Host Webcast Conference C...
GlobeNewswire
11/4/2021
Prothena Reports Third Quarter 2021 Financial Results and Business Highlights
GlobeNewswire
8/5/2021
Prothena Reports Second Quarter 2021 Financial Results and Business Highlights
GlobeNewswire
7/26/2021
Prothena Presents New Data from Robust Alzheimer’s Portfolio at the Alzheimer’s Association Internat...
GlobeNewswire
7/20/2021
Prothena to Present Data from Two of its Alzheimer’s Disease Programs at the Alzheimer’s Association...
GlobeNewswire
7/12/2021
Prothena and Novo Nordisk Announce Acquisition Agreement for Prothena’s ATTR Amyloidosis Programme
GlobeNewswire
6/24/2021
Prothena Announces Bristol Myers Squibb Opt-in of Anti-Tau PRX005 as the First Program from Global N...
GlobeNewswire
6/10/2021
Prothena to Participate in JMP Securities Life Sciences Conference on June 16
GlobeNewswire
5/20/2021
Prothena Announces Appointment of Sanjiv Patel, MBBS, to its Board of Directors
GlobeNewswire
5/11/2021
Prothena Reports First Quarter 2021 Financial Results and Provides Updated Financial Guidance and R&...